Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) General Information
Description
A portfolio of healthcare assets. The assets covers MiRInform Thyroid and Pancreas tests, intellectual property related to these and other tests in development for thyroid cancer and an extensive 5,000 plus tissue sample biobank.
Contact Information
Corporate Office
- 2150 Woodward Street
- Suite 100
- Austin, TX 78744
- United States
Corporate Office
- 2150 Woodward Street
- Suite 100
- Austin, TX 78744
- United States
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) FAQs
-
Where is Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) headquartered?
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) is headquartered in Austin, TX.
-
What industry is Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) in?
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets)’s primary industry is Buildings and Property.
-
Is Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) a private or public company?
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) is a Private company.
-
What is the current valuation of Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets)?
The current valuation of Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) is .
-
What is Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets)’s current revenue?
The current revenue for Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) is .
-
Who are Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets)’s investors?
Asuragen has invested in Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets).
-
When was Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) acquired?
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) was acquired on 13-Aug-2014.
-
Who acquired Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets)?
Asuragen (MiRInform Thyroid and Pancreas Cancer Test Assets) was acquired by Interpace Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process